Fact CheckerSign in

NCT07516691Not yet recruiting

Evaluation of a New Strategy to Approach the Transgender Sex Worker Populations and Their Clients for Access to a Preventive Sexual Health System Through the ORTIF Digital Teleconsultation Solution

Evaluation of a New Strategy to Approach the Transgender Sex Worker Populations and Their Clients for Access to a Preventive Sexual Health System Through the ORTIF Digital Teleconsultation Solution E-PrevenT

Source: ClinicalTrials.gov · Last updated 8 Apr 2026

Brief summary (registry, in English)

The prevalence of HIV (Human Immunodeficiency Virus) and STIs (Sexually Transmitted Infections) is very high in the trans population, due to multifactorial components. The main risk factors for HIV in this population are unprotected receptive and insertive anal intercourse, multiple sexual partners, sex work, needles share for injecting drugs and hormones. Physical violence, sexual assault and lack of social and family support are supplementary social risk factors. Healthcare access is very limited in this socio-economic context. The population of transgender persons and their transmission chains (partners, clients, etc.) are highly exposed to HIV risk, but they are still "hidden" populations, not targeted by prevention programs. Innovative preventive strategies can improve sexual health services access for these specific populations.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
250 (estimated)
First submitted
1 Apr 2026
Start date
1 May 2026
Primary completion date
1 May 2028
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Diseases
HIV
NCT number
NCT07516691

What you commit to

  • Study type: Observational
  • Planned participants: 250
  • From 1 May 2026 to the primary completion date, 1 May 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Person under guardianship, curatorship or other French legal protections schemes

Who the study is looking for

  • 'For population of E-prevent telemedicine service users :
  • Individuals aged ≥18 years
  • Registered on a trans escort-client dating website or having sexual relations with trans individuals in exchange for money
  • Agreeing to complete at least one teleconsultation through the E-PrevenT program
  • Agreeing to provide a phone number and an email address for the teleconsultation
  • No verbal objection to participating in the study
    • For population of trans individuals invited to collaborate in the study (seeds of the RDS strategy):
  • Trans or non-binary individuals aged ≥18 years
  • Engaged in sexual activity in exchange for money (sex work)
  • Commitment to complete sexual health training sessions (twice per year)
  • No verbal objection to participating in the study

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Bichat - Claude-Bernard
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.